皇冠体育app

  Home>News Center>Bizchina
       
 

皇冠体育app steps up production and export of pharmaceuticals
(Xinhua)
Updated: 2004-06-18 10:43

皇冠体育app has become the second largest producer of pharmaceutical ingredients in the world with an annual output of 800,000 tons, according to sources with the CPhI 2004 that concluded Thursday in Shanghai.

The three-day event was an annual international convention on pharmaceutical ingredients.

Industry insiders revealed at the CPhI 2004 that 皇冠体育app now ranks first in the world in terms of annual production of five varieties of pharmaceutical chemicals. It annually turns out around 28,000 tons of penincillin, or 60 percent of the world total; 98,000 tons of Vitamin C, of which 54,000 tons are sold abroad, or more than 50 percent of the world total; and 10,000 tons of terramycin, or 65 percent of the total. Meanwhile, the nation also leads the world in manufacturing of doxycycline hydrochloride and cephalosporins.

皇冠体育app is also a major exporter of pharmaceutical chemicals in the world. Last year, it sold abroad US$3.7 billion worth of such products.

Though edging into the forefront of the world pharmaceutical industry, 皇冠体育app's pharmaceutical sector is not powerful enough as it is still beset with scattered distribution of production, low standards of research and development, low added value of products and insufficient number of new varieties, according to Cui Bing, secretary-general of the 皇冠体育app Import-Export Chamber of Medicine and Health-care Products.

Rough statistics show that there are now in 皇冠体育app more than 6,700 pharmaceutical enterprises, and 5,200 of them are smaller plants. Only about 15 percent of the total have obtained certificates of GMP, or good manufacturing practices, which involve a stream of manufacturing regulations initiated in the early 1960s in the United States.

The CPhI 2004 was held from June 15 to 17 at the Shanghai Everbright Convention & Exhibition Center.



 
  Story Tools  
   
  Related Stories  
   
Firms agree on drug joint venture
   
Xi'an-Janssen confident about prospects
   
Traditional medicine maker to go overseas
   
Officials call for medicine price cut
Advertisement